Contraception and Seizure Disorders
Presented by Anne Davis, MD MPH
Release Date: December 7, 2021
Expiration Date: December 7, 2022
Please complete the form at the bottom of this page in order to watch the archived webinar. You will be redirected to a new page to watch the webinar.
Physicians, CNMs, PAs, NPs and other healthcare professionals interested in OB/GYN and contraception.
Educational Needs Addressed
The Institute of Medicine estimates over one million people in the U.S. with reproductive capacity have epilepsy. People with seizure disorders face unique concerns related to their reproductive health. Join us for a discussion of the considerations for contraceptive and preconception counseling with patients who have seizure disorders.
Participants at the conclusion of this webinar will be able to:
- Describe the intersection of seizure disorder and reproductive health topics including contraception, fertility, and preconception considerations
- Discuss antiseizure medication interactions with contraception and the effect of contraception on seizures
- Apply new knowledge to reproductive health clinical scenarios and discuss management options
Katharine White, MD MPH
Vice-Chair of Academics, Department of OB/GYN, Boston Medical Center
Director of the Fellowship in Family Planning, Boston Medical Center
Associate Professor of Obstetrics and Gynecology, Boston University School of Medicine
Principal Investigator of Partners in Contraceptive Choice and Knowledge (PICCK)
Elisabeth Woodhams, MD MSc
Medical Director, BEACON Family Planning, Boston Medical Center
Associate Director of OB/GYN Residency Program, Boston Medical Center
Assistant Professor of Obstetrics and Gynecology, Boston University School of Medicine
Accreditor Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Anne Davis, MD MPH
Faculty Presenter is a consultant for Mylan Pharmaceuticals, Exeltis, and AbbVie. She does plan on discussing unlabeled/investigational uses of a commercial product (use of contraceptive hormones for Catamenial epilepsy).
Katharine White, MD MPH receives research support from Boston Medical Center via Bayer Pharmaceuticals, Merck & Co., Inc., and Evofem Biosciences grants, and was previously a consultant for FitBit. Elisabeth Woodhams, MD MSc, Jenn Farraye, NP, Natasha Lerner, MPA, Kristina Tavilla, MPH, and Elizabeth Raskin MPH(c) MSW(c) of Boston Medical Center have no relevant financial relationships to disclose.
The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies:
Sakina Flint, MS – Program Manager
Michael Burk, BS – Senior Program Manager
|Boston University School of Medicine
Barry M. Manuel Continuing Medical Education Office
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Partners in Contraceptive Choice and Knowledge. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Earn Credit
In order to successfully complete this activity, you are required to view the entire enduring webinar and complete a posttest and evaluation. The evaluation survey will appear at the end of this activity after the content presentation. In the last evaluation question select that you wish to receive CME credit.
How to Request a Certificate
By reviewing the course content and completing the posttest and evaluation, physicians are entitled to receive 1 AMA PRA Category 1 Credits™. To receive a certificate for your participation in this activity, you will need to complete the evaluation survey at the end of this activity and in the last question select that you wish to receive CME credit. PICCK will send your certificate directly to you via email. You can expect your certificate within two weeks of completing the evaluation survey.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. THIS PROGRAM DOES NOT REPLACE YOUR HOME COUNTRY’S LAWS, REGULATIONS, AND GUIDELINES CONCERNING MEDICAL CARE AND DRUG PRESCRIPTION ACTIVITIES. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
For questions about the program or technology, contact us.
For questions about accreditation, contact Boston University School of Medicine – CME Office at: (617) 358-5005 or email@example.com.